| Financial Year |
March 31 2023 |
| Monetary Funds |
527,620,274.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,418,190,878.92 |
| Accounts Receivable |
1,297,112,629.45 |
| Advances to Suppliers |
110,874,301.90 |
| Other Receivables |
20,986,649.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
535,657,226.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,525,107.32 |
| Other Current Assets |
21,428,333.12 |
| Total Current Assets |
4,345,948,929.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
37,367,329.53 |
| Long-term Equity Investment |
45,890,503.88 |
| Investment Properties |
-- |
| Fixed Assetes |
1,734,080,468.88 |
| Under-construction Projects |
3,021,502,478.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
682,883,232.77 |
| R&D expenses |
-- |
| Goodwill |
25,560,710.57 |
| Long-Term Deferred and Prepaid Expenses |
3,768,963.15 |
| Deferred Income Tax Assets |
10,504,450.14 |
| Other Non-Current Assets |
78,608.90 |
| Sub-Total of Non-Current Assets |
5,564,363,709.57 |
| Total Assets |
9,910,312,638.80 |
| Short-Term Loans |
886,239,250.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
960,952,826.80 |
| Accounts Payable |
2,596,549,376.06 |
| Accounts Received In Advance |
8,682,722.78 |
| Employee Compensation Payable |
16,845,585.08 |
| Taxes Payable |
10,400,359.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,257,495.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
411,947,571.27 |
| Other Current Liabilities |
54,991,381.55 |
| Sub-Total of Current Liabilities |
5,028,739,328.48 |
| Long-term Loans |
701,090,833.31 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
894,636,734.37 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,578,647.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,641,991,788.51 |
| Total Liabilities |
6,670,731,116.99 |
| Paid-In Capital(Or Share Stock) |
989,923,600.00 |
| Capital Surplus |
2,274,946,681.33 |
| Surplus Reserve |
151,438,192.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-255,225,984.76 |
| Minority Stockholder's Interest |
71,538,726.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,168,042,795.58 |
| Owner's Equity（Stockholder's Equity） |
3,239,581,521.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,910,312,638.80 |
